List of works - David W. Mullins

Achieving policy recognition for community-based housing solutions: the case of self-help housing in England

scientific article published in 2017

Adaptive immunity programmes in breast cancer.

scientific article

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

scientific article

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

scientific article

BRAF inhibition alleviates immune suppression in murine autochthonous melanoma

scientific article published on 2 September 2014

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung

scientific article published on 23 August 2018

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

scientific article

CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity

scientific article published on 23 March 2015

CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases

scientific article published on 30 March 2017

Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas

scientific article

Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.

scientific article published on April 2013

Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology

scientific article published on 03 April 2020

Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway

scientific article

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

scientific article published on 27 November 2017

Immune responses to the HLA-A0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A0201-transgenic mice.

scientific article

Immunity to melanoma antigens: from self-tolerance to immunotherapy

scientific article

Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles

scientific article

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma

scientific article

Interleukin-12 Overcomes Paclitaxel-Mediated Suppression of T-Cell Proliferation ⬇️

scientific article published on November 1, 1998

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

scientific article

LNK suppresses interferon signaling in melanoma

scientific article published on 20 May 2019

Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.

scientific article

Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice ⬇️

scientific article published on November 15, 2001

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.

scientific article published on 5 June 2015

Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.

scientific article published on 06 March 2014

Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells

scientific article

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

scientific article

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

scientific article

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

scientific article

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

scientific article

Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.

scientific article published on 26 January 2017

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.

scientific article published in August 1997

Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.

scientific article published in October 1997

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells

scientific article published on 16 May 2015

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

scientific article published on 11 March 2016

The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells

scientific article

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases

scientific article

Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.

scientific article published in October 1998

Tumor-induced immune dysfunction: the macrophage connection.

scientific article published in September 1998

List of works by David W. Mullins

Achieving policy recognition for community-based housing solutions: the case of self-help housing in England

Adaptive immunity programmes in breast cancer.

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

BRAF inhibition alleviates immune suppression in murine autochthonous melanoma

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity

CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases

Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas

Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.

Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology

Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

Immunity to melanoma antigens: from self-tolerance to immunotherapy

Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma

Interleukin-12 Overcomes Paclitaxel-Mediated Suppression of T-Cell Proliferation ⬇️

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

LNK suppresses interferon signaling in melanoma

Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.

Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice ⬇️

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.

Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.

Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.

Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases

Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.

Tumor-induced immune dysfunction: the macrophage connection.

Immune responses to the HLA-A0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A0201-transgenic mice.